Literature DB >> 28783378

The latest advancements in Zika virus vaccine development.

Lanying Du1, Yusen Zhou2, Shibo Jiang1,3.   

Abstract

Entities:  

Keywords:  Flavivirus; Zika virus; advancement; challenge; vaccine

Mesh:

Substances:

Year:  2017        PMID: 28783378     DOI: 10.1080/14760584.2017.1363648

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  5 in total

Review 1.  Using immunocompromised mice to identify mechanisms of Zika virus transmission and pathogenesis.

Authors:  Clayton W Winkler; Karin E Peterson
Journal:  Immunology       Date:  2018-01-19       Impact factor: 7.397

2.  Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses.

Authors:  Wanbo Tai; Lei He; Yufei Wang; Shihun Sun; Guangyu Zhao; Chuming Luo; Pei Li; Haiyan Zhao; Daved H Fremont; Fang Li; Shibo Jiang; Yusen Zhou; Lanying Du
Journal:  Emerg Microbes Infect       Date:  2018-01-24       Impact factor: 7.163

3.  Transfusion-Transmitted Zika Virus Infection in Pregnant Mice Leads to Broad Tissue Tropism With Severe Placental Damage and Fetal Demise.

Authors:  Wanbo Tai; Denis Voronin; Jiawei Chen; Weili Bao; Debra A Kessler; Beth Shaz; Shibo Jiang; Karina Yazdanbakhsh; Lanying Du
Journal:  Front Microbiol       Date:  2019-01-23       Impact factor: 5.640

4.  Identification of relevant regions on structural and nonstructural proteins of Zika virus for vaccine and diagnostic test development: an in silico approach.

Authors:  E A Salvador; G A Pires de Souza; L C Cotta Malaquias; T Wang; L F Leomil Coelho
Journal:  New Microbes New Infect       Date:  2019-01-31

5.  Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.

Authors:  Wanbo Tai; Jiawei Chen; Yusen Zhou; Fang Li; Lanying Du; Guangyu Zhao; Qibin Geng; Lei He; Yuehong Chen
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.